Chemoinformaics analysis of 8-Formyl-2,5,7-trihydroxy-6-methylflavanone
| Molecular Weight | 314.293 | nRot | 2 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 19 |
| Exact Molecular Weight | 314.079 | nRing | 3 |
| Solubility: LogS | -3.55 | nHRing | 1 |
| Solubility: LogP | 2.876 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 42.5371 |
| nHD | 3 | BPOL | 17.5169 |
| QED | 0.733 |
| Synth | 3.436 |
| Natural Product Likeliness | 1.828 |
| NR-PPAR-gamma | 0.847 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.022 |
| CACO-2 | -5.015 |
| MDCK | 0.0000148 |
| BBB | 0.226 |
| PPB | 0.956413 |
| VDSS | 0.736 |
| FU | 0.0180392 |
| CYP1A2-inh | 0.316 |
| CYP1A2-sub | 0.166 |
| CYP2c19-inh | 0.092 |
| CYP2c19-sub | 0.222 |
| CYP2c9-inh | 0.265 |
| CYP2c9-sub | 0.726 |
| CYP2d6-inh | 0.074 |
| CYP2d6-sub | 0.203 |
| CYP3a4-inh | 0.149 |
| CYP3a4-sub | 0.278 |
| CL | 3.716 |
| T12 | 0.276 |
| hERG | 0.008 |
| Ames | 0.038 |
| ROA | 0.124 |
| SkinSen | 0.829 |
| Carcinogencity | 0.144 |
| EI | 0.419 |
| Respiratory | 0.44 |
| NR-Aromatase | 0.819 |
| Antiviral | Yes |
| Prediction | 0.840444 |